fda approvals in rcc and chronic itp, 2018 elcc highlights, and more
Published 6 years ago • 157 plays • Length 9:43
Download video MP4
Download video MP3
Similar videos
-
10:39
fda approvals in ovarian cancer, merkel cell carcinoma, itp, and more
-
10:47
fda approvals in myeloma and itp, applications accepted in myeloma and more
-
8:00
fda approval in rcc, european approvals in myeloma and melanoma, and 2016 aua highlights
-
1:34
fda approval of frontline nivolumab/ipilimumab combo in rcc
-
7:39
fda approvals in all, ovarian cancer, priority review in ctcl, and snda submitted in rcc
-
9:41
fda approvals in follicular lymphoma and prostate cancer, biosimilar is granted approval, and more
-
0:49
dr. fertrin on the fda approval of avatrombopag in itp
-
8:30
fda approvals in bladder cancer, nsclc, aml, hcc, and a breakthrough designation in nsclc
-
1:22
copy of dr. mcgregor on implications of the fda approval of pembrolizumab/axitinib in rcc
-
0:45
dr. choueiri on fda approval of lenvatinib/everolimus in rcc
-
0:29
dr. mckay on fda approval of frontline cabozantinib in rcc
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
1:40
dr. powles on fda approval of pembrolizumab plus axitinib in advanced rcc
-
1:06
dr. choueiri on fda approval of cabozantinib for rcc
-
3:05
alliance a021501: preoperative mfolfirinox /- hypofractionated rt for pancreatic cancer
-
2:36
kidney cancer research: fda approves immunotherapy combination
-
5:31
fda d.i.s.c.o.: fda approval of cabozantinib for hepatocellular carcinoma
-
2:23
romidepsin and azacitidine in patients with r/r t-cell lymphoma
-
0:37
welireg wins fda approval for advanced renal cell carcinoma, the second for the merck drug
Clip.africa.com - Privacy-policy